Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Hilda Haynes-Lewis, PhD, ANP-BC, AOCNP

Advertisement

Articles by Hilda Haynes-Lewis, PhD, ANP-BC, AOCNP

Hilda Haynes-Lewis

Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing Radiation

ByHilda Haynes-Lewis, PhD, ANP-BC, AOCNP,Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS
April 27th 2023

Hilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.

Advertisement

Latest Updated Articles

  • Hilda Haynes-Lewis
    Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing Radiation

    April 27th 2023



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Iberdomide for Relapsed or Refractory Multiple Myeloma

2

Prostate Cancer Risk Factors Do Not Predict Hormone Therapy Benefit

3

Ovarian Reserve Markers Predict Chemotherapy Benefit in Breast Cancer

4

Myeloma Care: Quad Therapies, Bispecifics, and the Role of Oncology Nurses

5

Advancing Frontline Treatment in Metastatic Triple-Negative Breast Cancer with ADCs

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us